Evidence map›Paper›PMID 29611055›Full record

ArticleVirchows Archiv : an international journal of pathology2018

The more the micropapillary pattern in stage I lung adenocarcinoma, the worse the prognosis-a retrospective study on digitalized slides.

Tamás Zombori, Tibor Nyári, László Tiszlavicz, Regina Pálföldi, Edit Csada, Tibor Géczi, Aurél Ottlakán, Balázs Pécsy, Gábor Cserni, József Furák

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Tamás ZomboriDepartment of Pathology, Faculty of Medicine, University of Szeged, Állomás u. 1., Szeged, H6725, Hungary. zomtam@gmail.com.ORCID http://orcid.org/0000-0002-0654-563X
Tibor NyáriDepartment of Medical Physics and Informatics, University of Szeged, Korányi fasor 9., Szeged, H6720, Hungary.
László TiszlaviczDepartment of Pathology, Faculty of Medicine, University of Szeged, Állomás u. 1., Szeged, H6725, Hungary.
Regina PálföldiCsongrád County, Hospital of Chest Diseases, Alkotmány u. 36., Deszk, H6772, Hungary.
Edit CsadaCsongrád County, Hospital of Chest Diseases, Alkotmány u. 36., Deszk, H6772, Hungary.
Tibor GécziDepartment of Surgery, University of Szeged, Semmelweis u. 8., Szeged, H6720, Hungary.
Aurél OttlakánDepartment of Surgery, University of Szeged, Semmelweis u. 8., Szeged, H6720, Hungary.
Balázs PécsyDepartment of Surgery, University of Szeged, Semmelweis u. 8., Szeged, H6720, Hungary.
Gábor CserniDepartment of Pathology, Faculty of Medicine, University of Szeged, Állomás u. 1., Szeged, H6725, Hungary.
József FurákDepartment of Surgery, University of Szeged, Semmelweis u. 8., Szeged, H6720, Hungary.
University of Szeged · HUBuda Health Center · HU

Funding

National Research, Development and Innovation Office grant GINOP-2.3.2-15-2016-00020
6 · The paper itself

Abstract

Although the majority of lung adenocarcinomas show mixed pattern, only the predominant component is taken into account according to the novel classification. We evaluated the proportion of different patterns and their impact on overall survival (OS) and disease-free survival (DFS). Patterns were recorded according to predominance and their proportions were rated and calculated by objective area measuring on digitalized, annotated slides of resected stage I lung adenocarcinomas. Spearman's rank correlation, Kaplan-Meier models and the log rank test were used for statistical evaluation. Two hundred forty-three stage I adenocarcinoma were included. Lepidic pattern is more frequent in tumours without recurrence (20 vs. 8%), and lepidic predominant tumours have favourable prognosis (OS 90.5%, DFS 89.4%), but proportions above 25% are not associated with improving outcome. Solid and micropapillary patterns are more frequent in patients with recurrence (48 vs. 5% and 13 vs. 4%) and predominance of each one is associated with unfavourable prognosis (OS 64.1%, DFS 56.3% and OS 28.1%, DFS 28.1%, respectively). Above 25%, a growing proportion of solid or micropapillary pattern is not associated with worsening prognosis. In contrast, tumours having micropapillary pattern as secondly predominant form a different intermediate group (OS 51.1%, DFS 57.8%). Our study was based on measured area of each growth pattern on all available slides digitalized. This is the most precise way of determining the size of each component from the material available. We propose using predominant and secondly predominant patterns for prognostic purposes, particularly in tumours having solid or micropapillary patterns.

Indexed as

AdenocarcinomaAdenocarcinoma of LungAdultAgedAged, 80 and overCell CycleCell ProliferationDisease-Free SurvivalFemaleHumansLung NeoplasmsMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingPrognosisGrowth patternLung adenocarcinomaPredominantSecond predominant componentSurvival

Identifiers

PMID29611055
OpenAlexW2795505107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.